Urolog. pro Praxi, 2010; 11(2): 75-77

Male hypogonadism - causes, diagnosis, treatment

doc.MUDr.Zdeněk Fryšák, CSc., MUDr.David Karásek, Ph.D., MUDr.Milan Halenka, Ph.D.
III. interní klinika FN a LF UP, Olomouc

The following lines should give the reader into the problems and so revive the awareness with regard to male hypogonadism, to be

able in their balance sheets to this diagnostic problem not only to think about, but also give assumption confirmed by commonly available

laboratory methods. On the shoulders of other experts, whom the challenge concern (urologist, sexologist, endocrinologist, and

geneticist) appropriately deep analysis of the patient troubles with the proposed treatment process including the possible practical

implementation, should remain.

Keywords: male hypogonadism, hypogonadotropic, hypergonadotropic

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fryšák Z, Karásek D, Halenka M. Male hypogonadism - causes, diagnosis, treatment. Urol. praxi. 2010;11(2):75-77.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bassas AL. Exploration of testicular function Endocrinol Nutr. 2009; 56: 18-31. Review. Go to original source... Go to PubMed...
    2. Blümel JE, Chedraui P, Gili SA, Navarro A, Valenzuela K, Vallejo S. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men? Maturitas. 2009; 63: 365-368. Go to original source... Go to PubMed...
    3. Foresta C, Selice R, Ferlin A, Garolla A. Recombinant FSH in the treatment of oligozoospermia. Expert Opin Biol Ther. 2009; 9: 659-666. Review. Go to original source... Go to PubMed...
    4. Lytras A, Tolis G. Reproductive disturbances in multiple neuroendocrine tumor syndromes. Endocr Relat Cancer. 2009; 16: 1125-1138. [PubMed - in process]. Go to original source... Go to PubMed...
    5. Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brain. Endocr Rev. 2009; 30: 713-743. Review. Go to original source... Go to PubMed...
    6. Porst H, Vardi Y, Akkus E, Melman A, Park NC, Seftel AD, Teloken C, Wyllie M. Standards for clinical trials in male sexual dysfunctions. J Sex Med 2010; 7: 414-444. PMID: 20092447 [PubMed - in process]. Go to original source... Go to PubMed...
    7. Poršová, Dutuit I. Mužský hypogonadismus. Nedostatečná funkce mužských pohlavních žláz. Praha: MAXDORF, 2005: 183 s.
    8. Rabijewski M, Zgliczyński W. Pathogenesis, evaluation and treatment of hypogonadism in men Endokrynol Pol. 2009; 60: 222-233. Review.
    9. Ramasamy R, Ricci JA, Palermo GD, Gosden LV, Rosenwaks Z, Schlegel PN. Successful fertility treatment for Klinefelter's syndrome. J Urol. 2009; 182: 1108-1113. Go to original source... Go to PubMed...
    10. Stárka S, Zamrazil V, et al. Praha: Základy klinické endokrinologie. Praha: MAXDORF, 2005: 378 s.
    11. Theodoraki A, Bouloux PM. Testosterone therapy in men. Menopause Int. 2009; 15: 87-92. Review. Go to original source... Go to PubMed...
    12. Traish AM, Feeley RJ, Guay A. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS J. 2009; 276: 5755-5767. Review. Go to original source... Go to PubMed...
    13. Vokurka, M, Hugo J, et al. Velký lékařský slovník. Praha: Maxdorf, 2004: 966 s.
    14. Zhuravlev VN, Frank MA, Gomzhin AI. Sexual functions of men with obstructive sleep apnoea syndrome and hypogonadism may improve upon testosterone administration: a pilot study. Andrologia. 2009; 41: 193-195. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.